Treatment of in-stent restenosis in the era of drug eluting stents: The rise and fall of brachytherapy

被引:0
|
作者
Mishkel, GJ [1 ]
Goswami, NJ [1 ]
Gill, JB [1 ]
Aguirre, FV [1 ]
Ligon, RW [1 ]
Moore, AL [1 ]
机构
[1] Mem Med Ctr, Prairie Heart Inst, Springfield, IL 62781 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1A / 1A
页数:1
相关论文
共 50 条
  • [31] Treatment of coronary in-stent restenosis with sirolimus-eluting stents
    Urban, P
    Guagliumi, G
    Gershlick, A
    Lotan, C
    Sousa, E
    Wijns, W
    Seth, A
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 671 - 671
  • [32] Treatment of Femoropopliteal In-Stent Restenosis With Paclitaxel-Eluting Stents
    Zeller, Thomas
    Dake, Michael D.
    Tepe, Gunnar
    Brechtel, Klaus
    Noory, Elias
    Beschorner, Ulrich
    Kultgen, Patricia L.
    Rastan, Aljoscha
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (03) : 274 - 281
  • [33] Vascular brachytherapy revisited for in-stent restenosis in the drug-eluting stent era: current status and future perspective
    Li Xiong-jie
    Rha, Seung-Woon
    Wani, Sunil-P
    Wang Lin
    Poddar, Kanhaiya-L
    Oh, Dong-Joo
    [J]. CHINESE MEDICAL JOURNAL, 2009, 122 (18) : 2174 - 2179
  • [34] Use of drug-eluting stents for the treatment of in-stent restenosis in routine clinical practice
    Belardi, JA
    Cura, F
    Albertal, M
    Padilla, L
    Solioz, G
    Balino, PP
    Pascua, JA
    Fava, C
    Berrocal, D
    Mendiz, O
    Grinfeld, L
    [J]. CORONARY ARTERY DISEASE, 2005, 16 (05) : 327 - 330
  • [35] OUTCOMES OF INTRAVASCULAR BRACHYTHERAPY IN RECURRENT DRUG-ELUTING IN-STENT RESTENOSIS
    Megaly, Michael
    Glogoza, Matthew
    Xenogiannis, Iosif
    Vemmou, Evangelia
    Nikolakopoulos, Ilias
    Willson, Laura
    Monyak, David J.
    Sullivan, Patsa
    Stanberry, Larissa
    Sorajja, Paul
    Chavez, Ivan
    Mooney, Michael R.
    Traverse, Jay
    Wang, Yale
    Garcia, Santiago
    Poulose, Anil
    Burke, M. Nicholas
    Brilakis, Emmanouil
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1151 - 1151
  • [36] Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis
    Megaly, Michael
    Glogoza, Matthew
    Xenogiannis, Iosif
    Vemmou, Evangelia
    Nikolakopoulos, Ilias
    Willson, Laura
    Monyak, David J.
    Sullivan, Patsa
    Stanberry, Larissa
    Sorajja, Paul
    Chavez, Ivan
    Mooney, Michael
    Traverse, Jay
    Wang, Yale
    Garcia, Santiago
    Poulose, Anil
    Burke, Martin Nicholas
    Brilakis, Emmanouil S.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (01) : 32 - 38
  • [37] Are drug eluting stents an attractive strategy to treat the diffuse in-stent restenosis?
    Carlevaro, O.
    Centeno, S.
    De Candido, L.
    Maffeo, H.
    Kevorkian, R.
    [J]. CIRCULATION, 2008, 118 (12) : E435 - E435
  • [38] Northwell intracoronary brachytherapy for the treatment of recurrent drug eluting stent in-stent restenosis (NITDI study group)
    Meraj, Perwaiz M.
    Patel, Krunalkumar
    Patel, Amitkumar
    Doshi, Rajkumar
    Srinivas, Guruprasad
    Jauhar, Rajiv
    Kaplan, Barry
    Garzon, Ruby
    Sharma, Anurag
    Cao, Yijian
    Molina, Ferney Diaz
    Sharma, Rajiv
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (01) : 41 - 46
  • [39] Patients with in-stent restenosis treated with sirolimus coated drug eluting stents
    Rau, M
    Maikowski, C
    Weber, M
    Zahn, R
    Schneider, S
    Senges, J
    Hamm, C
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 431 - 431
  • [40] Prospective comparison of sirolimus-eluting stents vs. intracoronary brachytherapy for the treatment of in-stent restenosis
    Ako, J
    Honda, Y
    Hassan, A
    Waseda, K
    Sonoda, S
    Hur, SH
    Fitzgerald, PJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 98H - 98H